American Bio Medica Corporation (ABMC)
OTCMKTS: ABMC · Delayed Price · USD
0.0003
0.00 (0.00%)
Apr 25, 2024, 10:29 AM EDT - Market closed
American Bio Medica Revenue
American Bio Medica had revenue of $331.00K in the twelve months ending September 30, 2023, down -73.60% year-over-year. In the year 2022, American Bio Medica had annual revenue of $913.00K, a decrease of -58.84%.
Revenue (ttm)
$331.00K
Revenue Growth
-73.60%
P/S Ratio
0.29
Revenue / Employee
$20,688
Employees
16
Market Cap
96.20K USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 913.00K | -1.31M | -58.84% |
Dec 31, 2021 | 2.22M | -1.93M | -46.52% |
Dec 31, 2020 | 4.15M | 492.00K | 13.46% |
Dec 31, 2019 | 3.66M | -217.00K | -5.60% |
Dec 31, 2018 | 3.87M | -1.04M | -21.20% |
Dec 31, 2017 | 4.91M | -695.00K | -12.39% |
Dec 31, 2016 | 5.61M | -708.00K | -11.21% |
Dec 31, 2015 | 6.32M | -968.00K | -13.29% |
Dec 31, 2014 | 7.29M | -1.61M | -18.09% |
Dec 31, 2013 | 8.89M | -449.00K | -4.81% |
Dec 31, 2012 | 9.34M | 71.00K | 0.77% |
Dec 31, 2011 | 9.27M | -1.15M | -11.03% |
Dec 31, 2010 | 10.42M | 695.00K | 7.15% |
Dec 31, 2009 | 9.73M | -2.93M | -23.16% |
Dec 31, 2008 | 12.66M | -1.22M | -8.76% |
Dec 31, 2007 | 13.87M | 34.00K | 0.25% |
Dec 31, 2006 | 13.84M | 823.00K | 6.32% |
Dec 31, 2005 | 13.02M | 774.00K | 6.32% |
Dec 31, 2004 | 12.24M | -243.00K | -1.95% |
Dec 31, 2003 | 12.48M | 2.17M | 21.06% |
Dec 31, 2002 | 10.31M | - | - |
Dec 31, 2001 | 0 | - | - |
Apr 30, 2000 | 7.65M | 615.00K | 8.74% |
Apr 30, 1999 | 7.04M | 4.84M | 219.91% |
Apr 30, 1998 | 2.20M | 1.59M | 260.14% |
Apr 30, 1997 | 610.88K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 371.62B |
Johnson & Johnson | 85.16B |
Merck & Co. | 60.12B |
AbbVie | 54.32B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.86B |
Abbott Laboratories | 40.11B |
ABMC News
- 2 years ago - ABMC Reports Third Quarter 2021 Results - Accesswire
- 2 years ago - ABMC Reports Second Quarter 2021 Results - Accesswire
- 3 years ago - ABMC Reports First Quarter 2021 Results - Accesswire